Snider Financial Group Increases Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Snider Financial Group increased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 19.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 24,000 shares of the financial services provider’s stock after buying an additional 3,970 shares during the quarter. iShares Biotechnology ETF comprises approximately 1.3% of Snider Financial Group’s portfolio, making the stock its 28th biggest holding. Snider Financial Group’s holdings in iShares Biotechnology ETF were worth $3,494,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in IBB. Williams Financial LLC acquired a new stake in shares of iShares Biotechnology ETF during the 2nd quarter worth $867,000. PVG Asset Management Corp acquired a new stake in iShares Biotechnology ETF during the 2nd quarter worth approximately $415,000. Avantax Advisory Services Inc. raised its holdings in iShares Biotechnology ETF by 38.4% in the first quarter. Avantax Advisory Services Inc. now owns 5,287 shares of the financial services provider’s stock valued at $726,000 after buying an additional 1,466 shares during the period. Concourse Financial Group Securities Inc. lifted its position in iShares Biotechnology ETF by 22.4% during the second quarter. Concourse Financial Group Securities Inc. now owns 656 shares of the financial services provider’s stock valued at $90,000 after buying an additional 120 shares in the last quarter. Finally, Raymond James & Associates grew its stake in iShares Biotechnology ETF by 4.4% during the second quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock worth $26,047,000 after buying an additional 7,931 shares during the period. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $144.45 on Thursday. The firm has a fifty day moving average of $144.78 and a 200-day moving average of $141.57. iShares Biotechnology ETF has a 52-week low of $116.70 and a 52-week high of $150.57.

iShares Biotechnology ETF Announces Dividend

The business also recently declared a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were issued a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.